UK safari park announces the birth of three lion cubs
The cubs arrived in April to 12-year-old Amber, and have just had their first health checks, confirming two males and a female.
West Midlands Safari Park's veterinary team and keepers have named them Nero, Nox, and Nancy.
The next steps for the cubs will be an introduction to the outside world, with the keepers allowing them access to an outdoor area, next to the lion house.
Just like a domestic cat, the lion cubs will need their second lot of injections and another health check before they are allowed to venture into the great outdoors to meet guests.
The birth of the cubs is significant as lions are classed as 'vulnerable' in the wild by the International Union for the Conservation of Nature.
The lion cubs' arrival follows a recent baby boom at the park, including three Sumatran tiger cubs, an Indian rhino calf, two blesbok calves, and a barasingha fawn.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
a day ago
- Daily Mirror
NHS pays tribute to 'dedicated' doctor and family who died in plane crash
Dr Prateek Joshi was flying back to the UK with his wife Komi Vyas and their three children on the doomed Air India plane after they planned to settle down in the East Midlands In an emotional tribute University Hospitals of Derby and Burton (UHDB) and the NHS have shared their "deep sadness" following the tragic death of Dr Prateek Joshi and his family in the Air India plane crash this week. There were among the 242 passengers and crew on board, including 169 Indian nationals, 53 Brits, seven Portuguese nationals and one Canadian. Harrowing stories of the dead continued to emerge on Friday - including more tributes for Dr Joshi and his family who posted a selfie of them innocently smiling after boarding the Boeing 787 plane before it took off. Dr Joshi, 43, worked as a consultant radiologist at the Royal Derby Hospital and Queen's Hospital Burton for four years, after moving to Derby from India in 2021. He was flying back to the UK with his wife Komi Vyas – a fellow doctor - their daughter Miraya, eight, and twin sons, Pradyut and Nakul, five, who planned to settle down in the East Midlands. The NHS has released a new tribute to the doctor and his family on Friday. Dr Rajeev Singh, Consultant Radiologist and Clinical Director for Imaging at UHDB, who knew the family well has shared some words which truly capture the person Prateek was. Dr Singh said: "Prateek was full of joy, he was a wonderful man, friend, husband and father, and an exceptional Radiologist who was highly respected in his field. He approached everything with a smile, radiated positivity and had a great sense of humour. "He moved to Derby, from India, in 2021, quickly becoming a beloved colleague. He often entertained colleagues with stories about his passions outside of work, including his newly discovered love of fish and chips and enthusiasm for walking in the Peak District. "He touched the lives of so many people, both through his clinical work and as a colleague and friend to many. "It is hard to accept that a man with such a passion for life, and his beautiful young family, have been taken in this way. His passing has left a profound void, not only in his professional contributions but in the warmth and spirit that he gave to the world every day." Royal Derby Hospital described Dr Joshi as 'not only an excellent doctor for whom nothing was too much trouble, but also a warm, smiling and kind man who was a hugely liked and valued member of the team'. Stephen Posey, Chief Executive, added: "We are profoundly and deeply saddened at the loss of our dedicated and talented colleague, Dr Prateek Joshi and his family. Prateek was not only an excellent doctor for whom nothing was too much trouble, but also a warm, smiling and kind man who was a hugely liked and valued member of the team. "We are privileged that Prateek chose to give his skills, talent and knowledge to the NHS, and he will be sorely missed by everyone who had the pleasure of working with him." The NHS statement concluded: "Our thoughts are with Dr Joshi's family, friends and colleagues, and everyone who has been impacted by this tragedy, which is being felt across the world and within our local communities."
South Wales Argus
2 days ago
- South Wales Argus
UK safari park announces the birth of three lion cubs
The cubs arrived in April to 12-year-old Amber, and have just had their first health checks, confirming two males and a female. West Midlands Safari Park's veterinary team and keepers have named them Nero, Nox, and Nancy. The next steps for the cubs will be an introduction to the outside world, with the keepers allowing them access to an outdoor area, next to the lion house. Just like a domestic cat, the lion cubs will need their second lot of injections and another health check before they are allowed to venture into the great outdoors to meet guests. The birth of the cubs is significant as lions are classed as 'vulnerable' in the wild by the International Union for the Conservation of Nature. The lion cubs' arrival follows a recent baby boom at the park, including three Sumatran tiger cubs, an Indian rhino calf, two blesbok calves, and a barasingha fawn.
Reuters
3 days ago
- Reuters
India's OneSource eyes weight-loss drug boost to order book
June 12 (Reuters) - Indian contract drug manufacturer OneSource Specialty Pharma ( opens new tab expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top executive said on Monday. Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster injectable obesity drugs from Denmark's Novo Nordisk ( opens new tab and U.S.-based Eli Lilly (LLY.N), opens new tab. The active chemical compound in Novo's injectable Wegovy drug, semaglutide, will go off patent in 2026 in a few markets, including India. OneSource, which added 15 orders related to obesity and diabetes drugs in fiscal year 2025, said there are more in the pipeline. The global obesity market is estimated to be valued at $150 billion by the early 2030s. The company develops and manufactures complex biological drugs, vials, injectables, and soft gelatin capsules for larger pharmaceutical firms. "Our growth over the next few years will be driven by commercial launches of GLP-1s (weight-loss and diabetes drugs) by our global customers in all the key markets opening post patent expiry in 2026," CEO Neeraj Sharma told Reuters in an interview. Backed by increasing demand from weight-loss drug manufacturers, OneSource's order book across all service verticals should expand in line with 30% compound annual growth rate through fiscal year 2028, according to the CEO. OneSource, which competes with larger players such as Piramal Pharma ( opens new tab and Divi's ( opens new tab in contract research, development and manufacturing, is investing about $100 million to expand its drug device facilities, the CEO said. The company, which was demerged from Strides Pharma Science ( opens new tab and listed in January, is also looking at setting up a global footprint in manufacturing, both in Europe and the U.S.
